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INTRODUCTION
IgG4-related systemic sclerosing disease (IRSSD) is a new
clinical entity that is characterized by elevated levels of
serum IgG4; plasma cell infiltrates in tissues, including the
pancreas, lung, liver, kidney and breast; and a good
response to corticosteroid therapy.1-4 We report a case of a
patient with sclerosing cholangitis and pulmonary inflam-
matory pseudotumors. The diagnosis was made twelve
years after the onset of the initial symptoms. The aim of this
report is to describe a case with different radiological
patterns.
CASE REPORT
A 70-year-old male patient was referred to our institu-
tion in November 2009 for the evaluation of recurrent
pulmonary infiltrates. His clinical problems started in
1998. The patient was diagnosed with sclerosing cholan-
gitis after a cholecystectomy for gallstones. Dilatation of
the bile ducts using endoscopic retrograde cholangiopan-
creatography was performed. Symptomatic control was
achieved using ursodeoxycholic acid. No inflammatory
bowel disease was detected. In addition, the patient has
suffered from diabetes since 2000 and became insulin-
dependent just after diagnosis. In 2004, a lower lobe
pulmonary nodule was detected in a routine abdominal
computed tomography (CT). This same exam revealed no
signs of liver disease but demonstrated atrophy of the
pancreas and irregularities in the pancreatic ducts,
suggesting chronic pancreatitis. The pulmonary nodule
was resected and diagnosed as an inflammatory pseudo-
tumor. Four years later, the patient developed recurrent
episodes of dyspnea and fatigue. Chest CTs over the
years showed different image patterns and indicated pre-
dominantly bilateral peripheral nodules or subpleural
consolidations with a ground-glass halo (Figure 1 and 2).
The symptoms and signs improved after treatment with
prednisone but reoccurred after tapering off of the
corticosteroid treatment. Several tests were performed to
look for evidence of autoimmune diseases, but these tests
yielded negative results. The association of relatively rare
conditions, such as an indolent sclerosing cholangitis,
presumed autoimmune pancreatitis with endocrine insuf-
ficiency, and inflammatory pseudotumors of the lung, led
us to the diagnosis of IRSSD. The serum IgG4 concentra-
tion was 936 UI (reference value: ,140 UI). An anatomo-
pathological revision of the previous pulmonary nodule
biopsy revealed a dense fibrosis with plasmacytic infiltra-
tion and focal lymphoid aggregation in the nodular
lesion. Small numbers of eosinophils were detected (,5
cells/high-power field [HPF] in most areas). Some vessels
were partially or completely obstructed by inflammatory
cells. Most of the infiltrating plasma cells were positive
for IgG4, and the IgG4/IgG ratio was greater than 90%
(Figure 3). Light chain restriction (normal range of
kappa:lambda) and Epstein-Bar virus encoded RNA,
which was evaluated using in situ hybridization, were
not detected. There were no signs of malignancy.
The patient received prednisone (20 mg/daily) with
recrudescence of the tomographic findings. We prescribed
a low dose of prednisone (10 mg/daily) to avoid recrudes-
cence of the pulmonary nodules.
DISCUSSION
High serum IgG4 that is associated with sclerosing
pancreatitis was first described in 2001 by Hamano and
colleagues and suggests a distinct disease entity due to its
responsiveness to corticosteroids.5 This report and other
reports have indicated the involvement of multiple organs
containing inflammatory pseudotumors with plasma cells
expressing IgG4, such as the pancreas, bile ducts, gallblad-
der, breast, salivary glands, retroperitoneum, kidney, lung,
and prostate.1-4 Recently, a new clinical entity, IRSSD, has
been proposed as an etiology for hyper-IgG4 gammaglobu-
linemia and IgG4 plasma cell infiltrates in multiple organs
and is responsive to glucocorticoids.1-3,6
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Zen et al. examined clinical and histological features of
inflammatory pseudotumors and described lesions that are
characterized by dense lymphoplasmacytic infiltrates inter-
mixed with fibrosis, eosinophilic infiltration, irregular nar-
rowing of the bronchioles that are entrapped in nodules,
obliterative phlebitis or arteritis, and an interstitial pneumo-
nia pattern at the boundaries of nodules. Immunostaining
revealed many IgG4+ plasma cells diffusely distributed
within the nodules, and the ratio of IgG4+ plasma cells to
other plasma cells was extraordinarily high.7-8
Convincing clinical criteria have not been clearly defined.
IgG4 serum levels are frequently elevated in the majority of
patients (above 140 mg/dl). However, 25% of patients
display normal IgG4 levels.2 Immunostaining has revealed
Figure 1 - Chest computer tomography (CT) scans showing different image patterns along the years. A: December, 2004: the initial
clinical presentation as a subpleural solitary pulmonary nodule in the right inferior lobe with adjacent subpleural opacities. The nodule
was resected and diagnosed as an inflammatory pseudotumor. B: Three years later, CT scans with multiple spiculated pulmonary
nodules surronded with ground glass halo and architectural distortion of the adjacent parenchyma. C and D: June, 2008: Pulmonary
nodule with ground glass halo in the middle lobe along with consolidation in the left inferior lobe resembling organizing pneumonia.
There was a complete response after corticosteroid treatment.
Figure 2 - Chest CT scans obtained in 2009. On the left column, solitary pulmonary nodule in the upper right lobe along with
parenchimal bands in the inferior right lobe. Five months later, the right upper nodule disappeared, but other nodules surrounded
with ground glass halo appeared in the inferior lobes bilaterally.
IgG4-related systemic sclerosing disease
Dias OM et al.
CLINICS 2011;66(11):1983-1986
1984
IgG4+ plasma cells. IgG4+ cells that number between .60
and 100 cells/high-power field (HPF) and a ratio IgG4+/
IgG+ cells between .40% and 50% are highly suggestive of
IgG4-related disease.9
Although its prevalence is still unknown, previous
studies have reported an increased incidence in male
patients in their sixties who usually present with dry cough
or dyspnea or are asymptomatic.1 Asian patients seem to
have a genetic predisposition for IRSSD.10 However, cases
in non-Asian patients, including the current case subject,
have also been reported.
Due to the heterogeneity of radiological presentations,
IRSSD must be included as a differential diagnosis of other
interstitial diseases. IRSSD is categorized into four major
subtypes: the solid nodular type; the round-shaped ground-
glass opacity type; the alveolar interstitial type, which
includes honeycombing, bronchiectasis, and diffuse
ground-glass opacities; and the bronchovascular type,
which is characterized by thickening of the bronchovascular
bundles and interlobular septa.11 To our knowledge, we
report herein the case with the longest radiological follow-
up (seven years) and the first case with multiple documen-
ted radiological patterns in the same patient. In addition, we
noticed a pattern of consolidation as a possible pulmonary
involvement of IRSSD.
Corticosteroids appear to be effective in the majority of the
reported cases. The most commonly used dosage is pre-
dnisolone at 1 mg/kg/day with gradual tapering every 1-2
weeks for a total treatment period of 11 weeks. Clinical
reports have also indicated spontaneous resolution without
treatment.10 However, relapses during corticosteroid taper-
ing are also possible, as in this current case. Therefore, low
dose prednisone may be necessary as a maintenance
treatment. Alternative drug regimens for corticosteroid-
resistant cases have not been studied. Treatment data were
extrapolated from clinical studies of patients with pancreatic
or biliary disease. The drug regimens used for the treatment
of lung disease were empirical.
In conclusion, when faced with inflammatory pseudotu-
mors (histologically corresponding to plasma cell granu-
loma) or migratory pulmonary infiltrates that respond to
corticosteroid therapy, the diagnosis of IRSSD should be
considered in the differential diagnosis. Accurate diagnoses
may lead to effective treatments and prevent unnecessary
lung resections.
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